Static Chart Revive Therapeutics Ltd.

Equities

Market Closed - Canadian Securities Exchange Other stock markets 01:48:37 2024-05-17 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	0.00%		-16.67%	-16.67%

Apr. 23	FDA Grants Revive Therapeutics Type C Meeting Request For Bucillamine Study to Treat Long COVID	MT
Apr. 23	Revive Therapeutics Brief: Announcing Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID	MT

Duration

Period